This is the authors' abstract. We don't add key points for this paper.
Background/Objectives: The central vein sign can help characterize multiple sclerosis (MS) lesions on MRI, but reading it takes specialist time and experience. We developed a compact convolutional neural network (CNN) and a deep feature engineering (DFE) pipeline for three-class classification of clinically labeled MR images. Methods: The MS Vein dataset contains 3181 axial FLAIR images from 154 participants in vein-positive, vein-negative, and control classes. MACDIBNeXt (about 6.5 million parameters) combines pooling-based attention downsampling, grouped convolution, and bottleneck and inverted bottleneck blocks. It was pretrained on Stable ImageNet1k and fine-tuned on a participant-level split (98 training, 25 validation, and 31 test participants). The DFE pipeline extracted 768 global average pooling features, selected 47 with CWINCA in participant-grouped folds of the training data, and classified them with tkNN. Results: On 635 held-out test images from 31 participants, the standalone CNN classified 527 correctly (82.99%; participant-cluster bootstrap 95% CI, 77.93–87.66%). DFE classified 571 correctly (89.92%; 85.47–93.82%), with 89.13% macro F1 and Cohen’s κ of 0.83. With participants resampled as clusters, the 6.93-point gain had a 95% CI of 3.33–10.63 points (p = 0.0002), and a cluster-adjusted McNemar test gave p = 0.0021. Grad-CAM activation was intracranial in the displayed examples. Conclusions: MACDIBNeXt with DFE gives promising internal, image-level results. Because the data are retrospective, single-center, and labeled on FLAIR images, external participant-level validation is required before clinical use.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Taşçı et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: